Loading...
Loading...
ASPI| Name | Value |
|---|---|
| Revenues | 1,101.6K |
| Cost of Revenue | 774.8K |
| Gross Profit | 326.8K |
| Operating Expense | 8,279.2K |
| Operating I/L | -7,952.3K |
| Other Income/Expense | -579.8K |
| Interest Income | 513.7K |
| Pretax | -8,532.2K |
| Income Tax Expense | -70.7K |
| Net Income/Loss | -8,446.2K |
ASP Isotopes Inc. is a pre-commercial stage advanced materials company specializing in the production, distribution, marketing, and sale of isotopes. The company's product portfolio includes Molybdenum-100, a non-radioactive isotope used in the medical industry, Carbon-14, and Silicon-28. Additionally, ASP Isotopes Inc. offers Uranium-235, an isotope of uranium catering to the carbon-free energy industry. By developing and supplying these isotopes, the company generates revenue through their sale to various industries, including medical and energy sectors.
